FDA grants breakthrough device designation for ArteraAI Prostate tool
Data supports combination intravesical chemotherapy for high-risk NMIBC
EMBARK: Significant OS gains seen with enzalutamide plus leuprolide in nmHSPC
FDA grants fast track designation to TRE-515 with 177Lu-PSMA-617 for mCRPC